TONTAT TONY enters KIROMIC BIOPHARMA, INC. with 402K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/16/2020ACC: 0001104659-20-115602
DirectorOfficer· CFO
Since Oct 2020
402K
Baseline shares
100% direct
402K
Direct ownership
1 position
273.07K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned402K
Total
402K direct402K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 402K | Direct |
| Total | 402K | 402K direct |
Derivative Holdings4
Restricted Stock Units
DirectUnderlying security
Common Stock
Underlying shares
21.11K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Stock Options
DirectUnderlying security
Common Stock
Underlying shares
8.59K
Shares owned
N/A
Exercise price
6.64
Expiration
—
Exercise window
—
Stock Options
DirectUnderlying security
Common Stock
Underlying shares
57.24K
Shares owned
N/A
Exercise price
11.88
Expiration
—
Exercise window
—
Restricted Stock Units
DirectUnderlying security
Common Stock
Underlying shares
186.13K
Shares owned
N/A
Exercise price
0
Expiration
—
Exercise window
—
Total
Underlying
273.07K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock | 0 | — | — | 21.11K | N/A |
| Stock Options Direct | Common Stock | 6.64 | — | — | 8.59K | N/A |
| Stock Options Direct | Common Stock | 11.88 | — | — | 57.24K | N/A |
| Restricted Stock Units Direct | Common Stock | 0 | — | — | 186.13K | N/A |
| Total | 273.07K | 0.00 | ||||